Ear­ly da­ta on Dai­ichi Sankyo’s Mer­ck-part­nered ADC; As­traZeneca’s Da­to-Dxd com­bo; more from Seagen: #ES­MO23 roundup

MADRID — Clin­i­cal re­searchers pre­sent­ed da­ta on hun­dreds of tri­als over the week­end at the Eu­ro­pean So­ci­ety for Med­ical On­col­o­gy Con­gress here in Spain.

Mer­ck and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER